Emma V. King

4.1k total citations · 1 hit paper
52 papers, 2.0k citations indexed

About

Emma V. King is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Emma V. King has authored 52 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Otorhinolaryngology and 11 papers in Surgery. Recurrent topics in Emma V. King's work include Cancer Immunotherapy and Biomarkers (13 papers), Head and Neck Cancer Studies (12 papers) and Immunotherapy and Immune Responses (4 papers). Emma V. King is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Head and Neck Cancer Studies (12 papers) and Immunotherapy and Immune Responses (4 papers). Emma V. King collaborates with scholars based in United Kingdom, United States and Canada. Emma V. King's co-authors include Gareth J. Thomas, Christian H. Ottensmeier, Toby Mellows, Pandurangan Vijayanand, Matthew J. Ward, Oliver Wood, Grégory Seumois, Tilman Sánchez-Elsner, Eva M. Garrido‐Martín and James Clarke and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emma V. King

49 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer

2017 380 citations Anusha-Preethi Ganesan, James Clarke et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma V. King United Kingdom	18	954	694	467	341	320	52	2.0k
Dan P. Zandberg United States	23	1.3k 1.4×	530 0.8×	457 1.0×	655 1.9×	277 0.9×	100	2.2k
Peter Oppelt United States	31	800 0.8×	336 0.5×	431 0.9×	415 1.2×	236 0.7×	149	2.8k
Adam Luginbuhl United States	24	648 0.7×	230 0.3×	525 1.1×	534 1.6×	381 1.2×	157	2.2k
Donald T. Weed United States	26	719 0.8×	331 0.5×	408 0.9×	426 1.2×	100 0.3×	82	2.0k
Giovana R. Thomas United States	19	686 0.7×	312 0.4×	437 0.9×	446 1.3×	341 1.1×	40	1.6k
Jessica Flynn United States	25	1.3k 1.4×	305 0.4×	275 0.6×	92 0.3×	277 0.9×	107	2.0k
Paul Swiecicki United States	21	660 0.7×	159 0.2×	540 1.2×	483 1.4×	190 0.6×	96	1.7k
David M. Neskey United States	27	801 0.8×	165 0.2×	490 1.0×	618 1.8×	226 0.7×	67	2.0k
Mascha Binder Germany	28	866 0.9×	609 0.9×	729 1.6×	55 0.2×	193 0.6×	136	2.9k
Y. M. Dennis Lo Hong Kong	29	789 0.8×	193 0.3×	972 2.1×	253 0.7×	811 2.5×	54	2.9k

Countries citing papers authored by Emma V. King

Since Specialization

Citations

This map shows the geographic impact of Emma V. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma V. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma V. King more than expected).

Fields of papers citing papers by Emma V. King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma V. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma V. King. The network helps show where Emma V. King may publish in the future.

Co-authorship network of co-authors of Emma V. King

This figure shows the co-authorship network connecting the top 25 collaborators of Emma V. King. A scholar is included among the top collaborators of Emma V. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma V. King. Emma V. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Chang Woo, Jia Wei, R. M. Norman, et al.. (2025). Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma. The Journal of Laryngology & Otology. 139(8). 730–737. 1 indexed citations

King, Emma V., et al.. (2024). Evaluation of a mobile COVID-19 vaccination van outreach service in an outer South London borough. Journal of Public Health. 46(2). e258–e260. 1 indexed citations

Witzleben, Adrian von, Jaya Thomas, Cornelia Brunner, et al.. (2024). Immune checkpoint expression on tumor-infiltrating lymphocytes (TIL) is dependent on HPV status in oropharyngeal carcinoma (OPSCC) – A single-cell RNA sequencing analysis. Oral Oncology. 159. 107107–107107. 2 indexed citations

Jia, Wei & Emma V. King. (2023). The Role of Robotic Surgery in Laryngeal Cancer. Otolaryngologic Clinics of North America. 56(2). 313–322. 2 indexed citations

Rafaloff, Gary, et al.. (2023). Investigating trial design variability in trials of disease-modifying therapies in Parkinson’s disease: a scoping review protocol. BMJ Open. 13(12). e071641–e071641.

Chan, Jeffrey Shi Kai, Emma V. King, Leonardo Roever, et al.. (2023). Virtual medical research mentoring. The Clinical Teacher. 20(4). e13598–e13598.

Wang, Yueying, et al.. (2023). Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin‐induced myocardial injury. SHILAP Revista de lepidopterología. 2(4). 253–264. 14 indexed citations

Rogel, Anne, Stephen M. Thirdborough, Florence Depontieu, et al.. (2022). Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies. JCI Insight. 7(19). 8 indexed citations

Lee, Sharen, Jiandong Zhou, Keith Sai Kit Leung, et al.. (2022). Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong. Cardiovascular Drugs and Therapy. 37(3). 561–569. 29 indexed citations

10.

Nenclares, Pablo, Derfel ap Dafydd, Izhar Bagwan, et al.. (2020). Head and neck mucosal melanoma: The United Kingdom national guidelines. European Journal of Cancer. 138. 11–18. 30 indexed citations

11.

Kehagia, Angie A., et al.. (2020). Introducing the Parkinson’s KinetiGraph into Routine Parkinson’s Disease Care: A 3-Year Single Centre Experience. Journal of Parkinson s Disease. 10(4). 1827–1832. 20 indexed citations

12.

Reeves, Emma, Oliver Wood, Christian H. Ottensmeier, et al.. (2019). HPV Epitope Processing Differences Correlate with ERAP1 Allotype and Extent of CD8+ T-cell Tumor Infiltration in OPSCC. Cancer Immunology Research. 7(7). 1202–1213. 26 indexed citations

13.

Lewer, Dan, Joseph Freer, Emma V. King, et al.. (2019). Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis. Addiction. 115(6). 1011–1023. 106 indexed citations

14.

Best, Karin M., et al.. (2018). Quality of online otolaryngology health information. The Journal of Laryngology & Otology. 132(6). 560–563. 16 indexed citations

15.

Chakravarthy, Ankur, Andrew J.S. Furness, Kroopa Joshi, et al.. (2018). Pan-cancer deconvolution of tumour composition using DNA methylation. Nature Communications. 9(1). 3220–3220. 195 indexed citations

16.

Wood, Oliver, James Clarke, Jeongmin Woo, et al.. (2017). Head and Neck Squamous Cell Carcinomas Are Characterized by a Stable Immune Signature Within the Primary Tumor Over Time and Space. Clinical Cancer Research. 23(24). 7641–7649. 16 indexed citations

17.

Ganesan, Anusha-Preethi, James Clarke, Oliver Wood, et al.. (2017). Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nature Immunology. 18(8). 940–950. 380 indexed citations breakdown →

18.

Wood, Oliver, Jeongmin Woo, Grégory Seumois, et al.. (2016). Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget. 7(35). 56781–56797. 90 indexed citations

19.

King, Emma V., Christian H. Ottensmeier, & Kevin G. Pollock. (2015). Novel Approaches for Vaccination Against HPV-Induced Cancers. Current topics in microbiology and immunology. 405. 33–53. 1 indexed citations

20.

Sheppard, Zoë A, et al.. (2012). Comparison of techniques for identification of peripheral vestibular nystagmus. The Journal of Laryngology & Otology. 126(12). 1209–1215. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact